Biotech company Windtree announced that it has received $520 million in financing, 99% of which will be used to purchase BNB
-
最新报道：According to the news from the Coin World Network, on July 25, the US biotechnology company Windtree Therapeutics (NASDAQ: WINT) announced on July 24 that it had signed a common stock purchase agreement worth up to $500 million to establish an equity line of credit (ELOC) and reached an additional $20 million stock purchase agreement with Build and Build Corp. The company said that 99% of the two financings will be used to acquire BNB cryptocurrency to strengthen its innovative cryptocurrency funding strategy. Windtree CEO Jed Latkin said that this move is an important part of the company's diversified financial asset strategy, but the use of ELOC requires shareholder approval to increase authorized shares of common stock. Previously, Windtree had announced a strategic partnership with the cryptocurrency exchange Kraken to provide services for its BNB custody, trading and over-the-counter trading.
下一篇
New ChatGPT Agent Can Book, Browse, and Fill Forms—Just Don't Trust It Yet
- OpenAI's ChatGPT can now browse the web, fill out forms, and perform tasks autonomously as...
24小时热点
热点专题
413499